NonExomics is focused on the non-exome regions of the genome and has identified hundreds of potential new drug targets across rare diseases, neuropsychiatric disorders, and cancer.
The parts of our DNA that code for proteins make up around 2% of the human genome and are collectively known as the exome. The exome is the best studied and most well understood part of the genome, and is where the vast majority of known disease-causing variants are found. NonExomics has however identified mutations in nonexomal regions that are strongly associated with poorly diagnosed, poorly treated, or currently deemed incurable diseases.
NonExomics says it has identified – using AI and Proteogenomics – hundreds of new disease-associated biomarkers spanning more than 300 human diseases and has shown that these disease markers are potential drug targets. These nonexomic disease-specific targets include 150 rare diseases, schizophrenia and bipolar neuropsychiatry disorders, and 22 cancers.
BioTryp Therapeutics is University of Cambridge spin-out biotechnology company that focuses on the development of small molecules to inhibit biofilm formation, which causes 80% of …
Bastion Therapeutics is a pre-clinical stage biotechnology company focused on developing best-in-class Treg cell therapies, which can target the root causes of inflammatory disorders and …
HOVANA is a digital biology company tackling translational dysfunction as a driver of serious diseases. Leveraging insights into cellular reprogramming, HOVANA is inventing a new …
Founded in 2022, Couragene is a biotechnology company developing first-in-class in vivo genetic therapies using its proprietary delivery platforms. The company's technology holds potential for …
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to understand cancer in unprecedented and patient-specific detail. By moving beyond …
Founded in 2023, Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss. sCD83, which was discovered as an …